Angiotensinogen as a biomarker of acute kidney injury

Sheeba Habeeb Ba Aqeel, Alejandro Sanchez, Daniel Batlle*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

36 Scopus citations


Early recognition of acute kidney injury (AKI) is critical to prevent its associated complications as well as its progression to long term adverse outcomes like chronic kidney disease. A growing body of evidence from both laboratory and clinical studies suggests that inflammation is a key factor contributing to the progression of AKI regardless of the initiating event. Biomarkers of inflammation are therefore of interest in the evaluation of AKI pathogenesis and prognosis. There is evidence that the renin angiotensin aldosterone system is activated in AKI, which leads to an increase in angiotensin II (Ang II) formation within the kidney. Ang II activates pro-inflammatory and pro-fibrotic pathways that likely contribute to the progression of AKI. Angiotensinogen is the parent polypeptide from which angiotensin peptides are formed and its stability in urine makes it a more convenient marker of renin angiotensin system activity than direct measurement of Ang II in urine specimens, which would provide more direct information. The potential utility of urinary angiotensinogen as a biomarker of AKI is discussed in light of emerging data showing a strong predictive value of AKI progression, particularly in the setting of decompensated heart failure. The prognostic significance of urinary angiotensinogen as an AKI biomarker strongly suggests a role for renin-angiotensin system activation in modulating the severity of AKI and its outcomes.

Original languageEnglish (US)
Pages (from-to)759-768
Number of pages10
JournalClinical Kidney Journal
Issue number6
StatePublished - Dec 2017


  • AKI
  • Acute decompensated heart failure
  • Angiotensin II
  • Angiotensinogen
  • Renin-angiotensin system

ASJC Scopus subject areas

  • Nephrology
  • Transplantation


Dive into the research topics of 'Angiotensinogen as a biomarker of acute kidney injury'. Together they form a unique fingerprint.

Cite this